FREEHOLD, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision ...
Inserting a 4-Fr catheter into a 6-Fr guiding catheter—the so-called mother-child technique—greatly improves the success rate for treating lesions in which standard methods have failed. The “4-in-6” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback